The topography of nullomer-emerging mutations and their relevance to human disease
Nullomers are short DNA sequences (11-18 base pairs) that are absent from a genome; however, they can emerge due to mutations. Here, we characterize all possible putative human nullomer-emerging single base pair mutations, population variants and disease-causing mutations. We find that the primary determinants of nullomer emergence in the human genome are the presence of CpG dinucleotides and methylated cytosines. Putative nullomer-emerging mutations are enriched at specific genomic elements, including transcription start and end sites, splice sites and transcription factor binding sites. We also observe that putative nullomer-emerging mutations are more frequent in highly conserved regions and show preferential location at nucleosomes. Among repeat elements, Alu repeats exhibit pronounced enrichment for putative nullomer-emerging mutations at specific positions. Finally, we find that disease-associated pathogenic mutations are significantly more likely to cause emergence of nullomers than their benign counterparts.
Authors
- Candace S. Y. Chan (ORCID: https://orcid.org/0000-0001-9667-7996)
- Austin Montgomery (ORCID: https://orcid.org/0000-0003-0374-4390)
- Martin Hemberg (ORCID: https://orcid.org/0000-0001-8895-5239)
- Ilias Georgakopoulos‐Soares (ORCID: https://orcid.org/0000-0003-3641-1488)
- Nikol Chantzi (ORCID: https://orcid.org/0009-0005-4947-0745)
- Nadav Ahituv (ORCID: https://orcid.org/0000-0002-7434-8144)
- Georgios Christos Tsiatsianis
- Ioannis Mouratidis (ORCID: https://orcid.org/0000-0002-1025-8780)
Institutions
- Brigham and Women's Hospital (US)
- Pennsylvania State University (US)
- University of California, San Francisco (US)
- Institute of Human Genetics (PL)
- Penn State Milton S. Hershey Medical Center (US)
Publication Details
- Journal
- Computational and Structural Biotechnology Journal
- Published
- 2024-12-25
- DOI
- https://doi.org/10.1016/j.csbj.2024.12.026
- Citations
- 1
- Primary Topic
- Genomics and Rare Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.55
Funders
- University of Pennsylvania
- Pennsylvania State University
- National Institutes of Health
- University of California, San Francisco
- Penn State College of Medicine
- National Institute of General Medical Sciences